Journal article
The Case for Brachytherapy: Why It Deserves a Renaissance
Advances in radiation oncology, v 6(2), 100605
01 Mar 2021
PMID: 33723523
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The recent global events related to the coronavirus disease of 2019 pandemic have significantly changed the medical landscape and led to a shift in oncologic treatment perspectives. There is a renewed focus on preserving treatment outcomes while maintaining medical accessibility and decreasing medical resource utilization. Brachytherapy, which is a vital part of the treatment course of many cancers (particularly prostate and gynecologic cancers), has the ability to deliver hypofractionated radiation and thus shorten treatment time. Studies in the early 2000s demonstrated a decline in brachytherapy usage despite data showing equivalent or even superior treatment outcomes for brachytherapy in disease sites, such as the prostate and cervix. However, newer data suggest that this trend may be reversing. The renewed call for shorter radiation courses based on data showing equivalent outcomes will likely establish hypo-fractionated radiation as the standard of care across multiple disease sites. With shifting reimbursement, brachytherapy represents the pinnacle in hypofractionated, conformal radiation therapy, and with extensive long-term data in support of the treatment modality brachytherapy is primed for a renaissance. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.
Metrics
Details
- Title
- The Case for Brachytherapy: Why It Deserves a Renaissance
- Creators
- Vonetta M. Williams - University of WashingtonJenna M. Kahn - Oregon Health & Science UniversityNikhil G. Thaker - Arizona OncologySushil Beriwal - UPMC Hillman Cancer CenterPaul L. Nguyen - Dana-Farber/Harvard Cancer CenterDouglas Arthur - Virginia Commonwealth UniversityDaniel Petereit - Rapid City Regional HospitalBrandon A. Dyer - University of Washington
- Publication Details
- Advances in radiation oncology, v 6(2), 100605
- Publisher
- Elsevier
- Number of pages
- 6
- Grant note
- R01CA240080-01 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:000717463300011
- Scopus ID
- 2-s2.0-85101944274
- Other Identifier
- 991021897271204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging